SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

JENBURKT PHARMACEUTICALS

BSE: 524731 09 Sep 2025
Healthcare
₹ 1174
Jenburkt Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

JENBURKT PHARMACEUTICALS - Share Price & Details

Market Cap
₹514.0
High /Low
1,410 / 920.0
Stock P/E
15.9
Book Value
₹389.0
Dividend Yield
1.55
ROCE
27.2
ROE
₹19.9
Face Value
10.0
PEG Ratio
1.28
EVEBITDA
₹10.4
Debt
3.90
CMP / FCF
53.5
Debt to equity
₹0.02
NP Ann
32.1
High price all time
1,410
Piotroski score
₹6.0
Graham Number
802.0
No. Eq. Shares
0.44
Net CF
₹3.24
Net profit
32.4
Price to book value
3.0
Interest Coverage
₹98.9
Low price all time
13.4
Industry PE
33.1
Reserves
₹167
Free Cash Flow
₹8.20

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
JENBURKT PHARMACEUTICALS LTD.NANANANA514.015.9
ONE GLOBAL SERVICE PROVIDER LINANANANA50619.2
MEDICAMEN BIOTECH LTD.389.1916.37384.491.2147550.1

Peer Comparison Chart


About JENBURKT PHARMACEUTICALS

Jenburkt Pharmaceuticals Ltd., with Security Code 524731, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Jenburkt Pharmaceuticals Faces Stabilization Amid Mixed Technical Indicators and Flat Financial Performance

(04 Sep 2025)
Jenburkt Pharmaceuticals has recently experienced a change in its evaluation, reflecting a shift in technical indicators.
Read more →

Jenburkt Pharmaceuticals Reports Decline in Net Sales Amid Rising Non-Operating Income in June 2025

(13 Aug 2025)
Jenburkt Pharmaceuticals has announced its financial results for the quarter ending June 2025, reporting net sales of Rs 35.53 crore, a decline from...
Read more →

Jenburkt Pharmaceuticals standalone net profit rises 4.99% in the June 2025 quarter

(13 Aug 2025)
Net profit of Jenburkt Pharmaceuticals rose 4.99% to Rs 7.79 crore in the quarter ended June 2025 as against Rs 7.42 crore during the previous quarter ended...
Read more →

Jenburkt Pharmaceuticals Limited (524731) Quarterly Results Are Out - Record-setting profit potential

(24 Jul 2025)
Jenburkt Pharmaceuticals Limited (524731) Quarterly Results Are Out ✌️【Market Discussions】✌️ Get real-time global stock data and expert...
Read more →

Jenburkt Pharmaceuticals Achieves All-Time High Amid Mixed Market Performance

(09 Jul 2025)
Jenburkt Pharmaceuticals' stock reached an all-time high of Rs. 1410 but experienced a decline despite the overall market's slight increase.
Read more →

Jenburkt Pharmaceuticals Achieves 52-Week High Amidst Sector Underperformance and Market Trends

(09 Jul 2025)
Jenburkt Pharmaceuticals has achieved a new 52-week high of Rs. 1410, reflecting significant growth in the Pharmaceuticals & Biotechnology...
Read more →

Company Updates